Bioequivalence Waivers: When the FDA Allows Generic Drugs to Skip Human Trials
January 3 2026Tag: in vitro dissolution
3 Jan
Bioequivalence Waivers: When the FDA Allows Generic Drugs to Skip Human Trials
Bioequivalence waivers let generic drug makers skip costly human trials when their products meet strict scientific criteria. Learn how the FDA approves these waivers using dissolution tests instead of blood samples.
Read More...